BIOMAT Database Logo BIOMAT Database Logo

Synthesis and immunostimulating properties of novel adamant-1-yl tripeptides. 2012

Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
Department of Chemistry, University of Zagreb, Zagreb, Croatia.

The aim of this work was to prepare L- and D-(adamant-1-yl)-Gly-L-Ala-D-isoGln peptides in order to study their adjuvant (immunostimulating) activities. Adjuvant activity of adamant-1-yl tripeptides was tested in the mouse model using ovalbumin as an antigen and in comparison to the peptidoglycan monomer (PGM; β-D-GlcNAc-(1→4)-D-MurNAc-L-Ala-D-isoGln-mesoDAP(εNH(2) )-D-Ala-D-Ala) and structurally related adamant-2-yl tripeptides.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
Synthesis and anticholinergic properties of 1-Adamant-1-yl-1-phenyl-3-N-pyrrolidino-1-propanol hydrochloride.
August 1972, Journal of medicinal chemistry,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
(1-Adamant-yl)(3-amino-phen-yl)methanone.
December 2011, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
(1-Adamant-yl)(4-amino-phen-yl)methanol.
April 2009, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
(1-Adamant-yl)(2-methyl-phen-yl)methanone.
November 2010, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
4-[(1-Adamant-yl)carbamo-yl]pyridinium chloride.
December 2010, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
(1-Adamant-yl)diphenyl-methano-l.
June 2010, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
2-(1-Adamant-yl)-1-(3-amino-phen-yl)ethanol.
September 2011, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
2-[2-(1H-Imidazol-1-yl)-2-adamant-yl]phenol.
January 2011, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
rac-2-{[1-(1-Adamant-yl)eth-yl]imino-meth-yl}-5-meth-oxy-phenol.
September 2011, Acta crystallographica. Section E, Structure reports online,
Rosana Ribić, and Lidija Habjanec, and Branka Vranešić, and Ruža Frkanec, and Srđanka Tomić
1,3-Bis(1-adamant-yl)imidazolium tetra-chloridoferrate(III).
October 2010, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!